<unk>  is used to treat hereditary tyrosinemia type 1 (HT-1) in patients from all ages, in combination with dietary restriction of tyrosine and phenylalanine. Since its first use for this indication in 1991, it has replaced liver transplantation as the first-line treatment for this ultra rare condition.
Nitisinone
Diiodohydroxyquinoline
Desmethylchlorotrianisene
Triphenylbromoethylene
Chlorotrianisene
Heptachlor
Paraquat
Phenylsilatrane